SIMCERE PHARMAC (Germany) Market Value
| S2P Stock | EUR 0.81 0.01 1.22% |
| Symbol | SIMCERE |
SIMCERE PHARMAC 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to SIMCERE PHARMAC's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of SIMCERE PHARMAC.
| 02/04/2023 |
| 12/25/2024 |
If you would invest 0.00 in SIMCERE PHARMAC on February 4, 2023 and sell it all today you would earn a total of 0.00 from holding SIMCERE PHARMAC GRP or generate 0.0% return on investment in SIMCERE PHARMAC over 690 days. SIMCERE PHARMAC is related to or competes with Merck KGaA, Haleon PLC, LIVZON PHARMAC, CanSino Biologics, Evotec SE, and Dermapharm Holding. More
SIMCERE PHARMAC Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure SIMCERE PHARMAC's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess SIMCERE PHARMAC GRP upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.34 | |||
| Information Ratio | 0.0729 | |||
| Maximum Drawdown | 18.98 | |||
| Value At Risk | (3.85) | |||
| Potential Upside | 5.13 |
SIMCERE PHARMAC Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for SIMCERE PHARMAC's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as SIMCERE PHARMAC's standard deviation. In reality, there are many statistical measures that can use SIMCERE PHARMAC historical prices to predict the future SIMCERE PHARMAC's volatility.| Risk Adjusted Performance | 0.0775 | |||
| Jensen Alpha | 0.2564 | |||
| Total Risk Alpha | 0.1245 | |||
| Sortino Ratio | 0.0665 | |||
| Treynor Ratio | 37.74 |
SIMCERE PHARMAC GRP Backtested Returns
SIMCERE PHARMAC appears to be dangerous, given 3 months investment horizon. SIMCERE PHARMAC GRP owns Efficiency Ratio (i.e., Sharpe Ratio) of 0.0751, which indicates the firm had a 0.0751% return per unit of standard deviation over the last 3 months. We have found twenty-eight technical indicators for SIMCERE PHARMAC GRP, which you can use to evaluate the volatility of the company. Please review SIMCERE PHARMAC's risk adjusted performance of 0.0775, and Coefficient Of Variation of 1140.9 to confirm if our risk estimates are consistent with your expectations. On a scale of 0 to 100, SIMCERE PHARMAC holds a performance score of 5. The entity has a beta of 0.0068, which indicates not very significant fluctuations relative to the market. As returns on the market increase, SIMCERE PHARMAC's returns are expected to increase less than the market. However, during the bear market, the loss of holding SIMCERE PHARMAC is expected to be smaller as well. Please check SIMCERE PHARMAC's jensen alpha, sortino ratio, maximum drawdown, as well as the relationship between the total risk alpha and treynor ratio , to make a quick decision on whether SIMCERE PHARMAC's existing price patterns will revert.
Auto-correlation | -0.35 |
Poor reverse predictability
SIMCERE PHARMAC GRP has poor reverse predictability. Overlapping area represents the amount of predictability between SIMCERE PHARMAC time series from 4th of February 2023 to 15th of January 2024 and 15th of January 2024 to 25th of December 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of SIMCERE PHARMAC GRP price movement. The serial correlation of -0.35 indicates that nearly 35.0% of current SIMCERE PHARMAC price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.35 | |
| Spearman Rank Test | -0.46 | |
| Residual Average | 0.0 | |
| Price Variance | 0.02 |
SIMCERE PHARMAC GRP lagged returns against current returns
Autocorrelation, which is SIMCERE PHARMAC stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting SIMCERE PHARMAC's stock expected returns. We can calculate the autocorrelation of SIMCERE PHARMAC returns to help us make a trade decision. For example, suppose you find that SIMCERE PHARMAC has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
SIMCERE PHARMAC regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If SIMCERE PHARMAC stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if SIMCERE PHARMAC stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in SIMCERE PHARMAC stock over time.
Current vs Lagged Prices |
| Timeline |
SIMCERE PHARMAC Lagged Returns
When evaluating SIMCERE PHARMAC's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of SIMCERE PHARMAC stock have on its future price. SIMCERE PHARMAC autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, SIMCERE PHARMAC autocorrelation shows the relationship between SIMCERE PHARMAC stock current value and its past values and can show if there is a momentum factor associated with investing in SIMCERE PHARMAC GRP.
Regressed Prices |
| Timeline |
Currently Active Assets on Macroaxis
Other Information on Investing in SIMCERE Stock
SIMCERE PHARMAC financial ratios help investors to determine whether SIMCERE Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in SIMCERE with respect to the benefits of owning SIMCERE PHARMAC security.